Bringing molecular diagnostics closer to where decisions are made.
Advancing access to molecular point-of-care testing through innovative technology for human health, veterinary medicine, and future applications.*
Extending access beyond the traditional laboratory.
Molecular diagnostics can provide valuable information to support clinical and operational decisions. Yet centralized testing, specialized equipment, and complex workflows can create barriers to timely access. PlusOne Bio is focused on expanding opportunities for molecular point-of-care testing across a broader range of healthcare and other testing settings.
Timely Answers
Practical Workflows
Broader Access
RHAM™ Technology
Rapid Molecular Testing. Compact Systems. Simplified Workflows.
PlusOne Bio leverages Pluslife's proprietary RHAM™ (RNase Hybridization Assisted Amplification) technology, an innovative approach to molecular testing designed for use beyond traditional laboratories. Pluslife's compact testing systems combine molecular detection technology with simplified workflows, supporting rapid results and decentralized testing across a range of applications.
Built on Innovation. Focused on Access.
Based in San Diego, California, PlusOne Bio focuses on market development, commercialization, and strategic partnerships throughout the Americas. Leveraging Pluslife's proprietary molecular diagnostic technologies, product development expertise, and manufacturing capabilities, PlusOne Bio works to identify opportunities and build partnerships that support broader access to molecular testing across human health, veterinary medicine, and emerging applications.
Let’s Advance Molecular Diagnostics Together.
PlusOne Bio welcomes inquiries from potential strategic partners, distributors, investors, and organizations interested in exploring opportunities to advance molecular diagnostics throughout the Americas.